In the Editorial entitled “Statins for Primary Prevention: The Debate Is Intense, but the Data Are Weak”¹ published in the November 15, 2016, issue of JAMA, incorrect data were reported in the text. In the first sentence of the second paragraph on the first page, the absolute benefit for use of statins should have been reported as 0.20%, rather than 0.43%, for cardiovascular mortality. This article was corrected online.

中文翻译：

---

文字中的数据不正确

在2016年11月15日出版的《美国医学会杂志》（JAMA）上，标题为《一级预防的他汀类药物：辩论激烈，但数据薄弱》的社论¹中报道了错误的数据。在第一页第二段的第一句中，使用他汀类药物对心血管死亡率的绝对收益应该报告为0.20％，而不是0.43％。本文已在线更正。